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Abstract
Purpose: The purpose of this study is to 1) evaluate perceived risk for diabetes among type 2 diabetes 
patients with different types of diabetes follow-up: diabetologist, general practitioner, or both (“combined 
follow-up”) in the community and university settings and 2) determine the prognostic factors for better/
higher risk perception of diabetes among these patients. 
Methods: In this cross-sectional study, we quantified diabetes risk perception using Walker’s RPS-DM 
survey. The PRIME-MD PHQ questionnaire was used to screen for mood and anxiety disorders. The 
global risk perception scores were coded in two categories (low/high) and compared across the various 
types of medical follow-up; univariate and multivariate logistic regression techniques were used to examine 
the association between perceived risk, patients’ sociodemographic factors, diabetes characteristics and 
psychological profile. 
Results: Univariate analysis in logistic regression showed that having combined diabetes follow-up in 
the university setting was significantly associated with higher composite risk perception (OR=14; 95% CI 
3.56-55.05) compared to patients with either single provider type follow-up. Specifically, combined follow-
up, was linked to diabetes worry (OR=6.45; 95% CI 1.68-24.7), but also higher perceived risk for diabetes 
complications (OR=3.55; 95% CI 1.12-11.2). These analyses also showed that perceived risk for diabetes 
complications was associated with longer diabetes duration (OR=1.05; 95% CI 1.01-1.09), higher number of 
drug therapies (OR=1.35; 95% CI 1.08-1.69), increased microvascular complications (OR=1.47; 95% CI 1.03-
2.10) and increased vascular complications (OR=1.31; 95% CI 1.02-1.71).
Conclusions: Having combined follow-up in the same medical institution increases a patient’s perceived risk 
of the complications of his/her diabetic illness. Having a more accurate self-perception of potential diabetic 
complications may help patients make healthier and informed lifestyle choices. Future studies should further 
examine the association between combined provider follow-up and risk perception, and focus on how 
patient-provider relationships and follow-up impact diabetic patient outcomes.
Keywords: Type 2 diabetes mellitus, behavior, risk, ambulatory care, patient care team, general 
practitioner
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Background 
Despite the increased dissemination of evidence-based guide-
lines for diabetes management and improvements in health 
systems to deliver diabetes care, there are still many diabetes 
patients who do not receive appropriate treatment and/or 
who do not seek care. Patient-centred strategies are necessary 
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for outreach to these patient populations. Currently, there is 
considerable interest about diabetes disease risk perception 
among patients – a known relevant predictor of patient ad-
herence to treatment plan [1,2]. Disease risk perception is of 
critical importance, as perception affects patient behaviour, 
which can affect diabetes outcomes and patient quality of life.
The perceived risk for type 2 diabetes is low in the general 
population of patients who have no known diabetes diagnosis. 
Relatively few patients know how to accurately bring their 
actual risk into line with perceived risk [3,4]. The difference 
between statistical risk and perceived risk can be accounted 
for by the fact that a subject’s reaction to risk is most often 
guided by protective emotions, rather than by logical reason-
ing (theory of heuristics in decision-making) [5].
"Optimistic bias" is the notion of feeling protected from the 
risk of developing a disease compared to other individuals of 
the same gender and age. This has especially been observed 
in patients who have a high risk of developing diabetes [4]. 
Following this, patients who then develop diabetes often 
have trouble evaluating their cardiovascular risk (compared 
to an objective value from confirmed risk scores) [6]. 
There is also a low fund of knowledge of the link between 
cardiovascular risk factors and cardiovascular disease outcome 
among these patients. However, this risk is better understood 
among the following groups of diabetic patients- 1) women, 2) 
patients with a higher level of education and 3) higher income, 
and by 4) patients who are on cardio-protective drug treat-
ments [7]. In addition to the misperception of cardiovascular 
risk, there is a tendency to underestimate the probability of 
a cardiovascular event when patients compare themselves 
to other patients in a similar clinical situation (relative risk), 
which can be partially explained by optimistic bias [8,9]. Other 
studies have also described an overestimation of absolute 
cardiovascular risk by diabetes patients [6,10,11].
Examining perceived risk among diabetes patients may 
prove useful in practice; for example, a patient’s fund of 
knowledge and predisposition for low (and inaccurate) 
perceived risk of their diabetes course may be linked to the 
way that patient healthcare is organised and delivered. The 
association between type of provider follow-up and patient 
perceived risk has not been studied thoroughly, although it 
has been shown that improved metabolic control is related to 
treatment by a multi-disciplinary point-of-care team [12,13]. 
One can speculate that perhaps patients are more educated 
in their disease course (and thus possess a better assessment 
of their risk) when cared for by a team of providers. 
Our study examined the association between “type of 
provider” diabetes follow-up (general practitioner vs. special-
ist diabetologist vs. “combined”/both) and perceived com-
posite risk of diabetes (including perceived risk for diabetic 
complications), as measured by validated Risk Perception 
Survey-Diabetes Mellitus (RPS-DM) [1]. We also examined 
how certain patient characteristics (well known to affect risk 
perception and aspects of diabetes control, like depression 
and diabetes duration) were related to this global measure 
of perceived risk [14,15]. Our hypothesis was that a combined 
follow-up would increase the perceived risk of diabetes, and 
specifically a higher perceived risk of diabetic complications. 
We also hypothesized that worry about diabetes (a major 
element of perceived risk) would be associated with anxiety 
disorders and depression. 
Methods
Study design, setting and participants
This cross-sectional study included patients who had type 2 
diabetes, were capable of communicating in French (read-
ing comprehension), and received their medical care at the 
Lausanne ambulatory clinic and university hospital. Between 
September 2010 and April 2011, we actively searched for 
this particular patient profile by systematically consulting all 
patients’ appointments in all physicians’ diaries of the Depart-
ment of Ambulatory Care and Community Medicine (PMU) or 
the Endocrinology and Diabetology Service of the University 
Hospital of Lausanne. For all these patients we checked the 
medical files for a type 2 diabetes diagnosis and competence 
in French.Those patients whose profile corresponded to the 
inclusion criteria were asked by their physicians if they would 
agree to participate in our survey. The patients were provided 
with an information sheet about the study.
Data collection and Primary Survey
Each participant completed three sets of questions over the 
telephone (interviews were conducted by a psychologist). The 
primary questionnaire asked about diabetes risk perception 
using Walker’s RPS-DM survey [1]. The original English version 
of the RPS-DM survey was converted to French and validated 
by “forward-backward translation” by our research team. 
Risk perception of diabetes evaluation   
The RPS-DM questionnaire [1] is unique in that it evaluates 
the worry related to the risk of developing diabetes-related 
complications, but also enables other risk perceptions to be 
determined and used for comparison (other diseases and 
environmental risk). For each item, the subjects state how 
strongly they agree/disagree with a statement, with four 
response options based on an ascending Likert scale. A cumu-
lative score is calculated for each group of questions. Higher 
scores indicate increased perceived risk of diabetes (Table 1). 
The survey is composed of five groups of questions (which 
partially correspond to the dimensions of risk as defined in 
P. Slovic’s studies [16,17]), for a total of 26 questions evaluat-
ing risk perception as related to diabetes and its associated 
complications. The questions investigate the following do-
mains: patients’ perception of control over diabetes,optimistic 
bias, risk perception for diseases that affect or have affected the 
patients (diabetes complications),worry of diabetes and envi-
ronmental risk perception, and patients’ knowledge regarding 
their diabetes.
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Provider follow-up type
Patients were recruited during visits to the Department of 
Ambulatory Care and Community Medicine (PMU) (17531 
consultations in 2013) or to the Endocrinology and Diabetol-
ogy Service of the University Hospital of Lausanne (17368 
consultations in 2013). We categorized patients according 
to the four specific types of follow-up found in the patient’s 
medical records:
1. (GP) General practitioner at the PMU (university primary 
care clinic) only
2. (DIAB) Diabetologist at the Diabetology Service of the 
university only
3. (C1) “Combined” follow-up by a diabetologist of the 
Diabetology Service of the university and by a general 
practitioner at the PMU
4. (C2) “Combined” follow-up by a diabetologist of the 
Diabetology Service of the university and by a non-PMU 
general practitioner (non-university primary care clinic)
We also paid attention to the comparison of C1 follow-up to 
the DIAB follow-up – one interest of the study was to examine 
the effect of a team-based care approach within the same 
institution, on a patient’s perceived risk of their diabetes.
Patients’ characteristics
Questions about socio-demographic characteristics came from 
the original RPS-DM survey. As in the Walker study, these were: 
gender, mean age, place of birth, educational level, annual 
household income, and employment status [1].
Patients were also surveyed by telephone for the possible 
presence of any anxiety-depressive disorder using an adapta-
tion of the English language Patient Health Questionnaire (PHQ). 
This diagnostic tool makes it possible to identify the primary 
psychiatric disorders encountered in general medicine, based 
on DSM-IV criteria. It has been validated in various primary 
care settings and populations in the United States (sensitivity 
75%, specificity 90%) [18]. The PHQ was adapted in the French 
version, the PRIME-MD [19], and was used for the first time for 
primary care settings in France by J. Norton [20]. 
Lastly, clinical data about metabolic syndrome and diabetes 
complications were linked to each respondent and used in 
the analysis.
Diabetes risk perception subscales Score 
ranges
Low risk 
range
Perception of control over diabetes 1-4 1-2.99
Diabetes-related worry 1-4 1-2.99
Optimistic bias 1-4 1-2.99
Perception of the risk related to the patient’s 
disease
1-5 1-2.99
Diabetes risk knowledge 0-5 0-3
Environment risk perception 1-4 1-2.49
Composite risk perception 1-4 1-2.49
Table 1. Diabetes risk perception subscales and score ranges. Statistical analysis
For this specific analysis, we calculated and used the composite 
risk perception, which incorporates all the questions, to yield 
a global mean score, which allows one to evaluate diabetes 
risk perception from a wider perspective. The risk perception 
scores were also coded in two categories as done in previous 
studies (low level=0 vs high level=1) [21]. Low level of each 
risk perception subscale was coded as follows: perception 
of control over diabetes: 1-2.99 (range 1-4), diabetes-related 
worry: 1-2.99, (range 1-4), optimistic bias: 1-2.99 (range 1-4), 
perception of the risk related to the patient’s disease: 1-2.99 
(range 1-5), diabetes risk knowledge: 0-3 (range 0-5), envi-
ronment risk perception: 1-2.49 (range 1-4), composite risk 
perception: 1-2.49 (range 1-4). Univariate analysis in logistic 
regression was used to examine the association between 
perceived risk score and provider type, socio-demographic 
factors, diabetes characteristics, disease-related complica-
tions, and psychological profile. Provider type and associated 
factors to the outcomes (p-value < 0.05) were then used in 
a backward procedure to fit multiple different multivariate 
models. The data was analysed using Stata 13 software 
(StataCorp. 2013. Stata Statistical Software: Release 13. College 
Station, TX: StataCorp LP.
Results      
Patient Characteristics and Follow-up group comparisons
A total of 168 patients participated in the study: 33 were 
followed by the ambulatory practice of the university clinic 
only (GP); 81 were followed by the Diabetology Service of 
the university clinic only (DIAB); 15 patients had a combined 
follow-up with the ambulatory practice and a diabetologist 
at the university (C1); 39 had a combined follow-up with the 
general practitioner from the non-university clinic and the 
Diabetology Service of the university clinic (C2); (Figure 1).
Socio-demographic characteristics 
(Tables 2a-2c) the median (iqr) age was 62 (12.5), and par-
ticipants were mostly men (73.2%). They had a high level of 
education (36.3% had been to a vocational school, and 26.8% 
held a tertiary qualification) and a moderately high level of 
income (49.4% had an annual income >50,000 CHF). 
 
Socio-demographic characteristics among different types 
of follow-up
Patients of the C1 group, compared to the DIAB group, were 
younger [median (iqr) age 55 (12), versus 62 (12.5)], had a 
tendency to have a lower economic status (33.3% with a 
20.000-30.000 CHF annual income versus 7.4%) and tended 
to be unemployed or disabled (33.3% unemployed versus 
18.5%). Patients of the C1 group, compared to the DIAB group, 
had younger diabetes (7 years versus 13 years), and more 
depressive disorders (13.3% with major depressive disorder 
versus 1.2%, 13.3% with minor depressive disorder versus 8.6%).
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Figure 1. Population groups of the study.
Socio-demographic characteristics Follow-up group
Number of patients N=168 
(%)
DIAB 
N=81 (48.2) 
GP 
N=33 (19.6)
C1 
N=15 (8.9)
C2  
N=39 (23.2)
Male, n (%) 123 (73.2) 55 (67.9) 23 (69.7) 12 (80) 33 (84.6)
Age, median (iqr¹) 62 (12.5) 62 (11) 60 (9) 55 (12) 64 (14)
Place of birth Switzerland 99 (58.9) 48 (59.2) 27 (69.2) 6 (40) 26 (66.7)
Educational level, n (%)
    Primary school
    Secondary school
    Professional school
    High school
    Third-level/university
23 (13.7)
31 (18.4)
61 (36.3)
8 (4.8)
45 (26.8 )
11 (13.6)
15 (18.5)
30 (37)
6 (7.4)
19 (23.5)
2 (6.1)
9 (27.3)
13 (39.4)
1 (3)
8 (24.2)
3 (20)
6 (40)
2 (13.3)
0
4 (26.7)
7 (17.9)
1 (2.6)
16 (41)
1 (2.6)
14 (35.9)
Annual household income*, n (%)                              
< 20.000 CHF 
     20.000-30.000 CHF
     30.000-50.000 CHF
> 50.000 CHF
     I don’t know 
     I refuse to answer
11 (6.5)
23 (13.7)
32 (19)
83 (49.4)
14 (8.3)
5 (3)
5 (6.2)
6 (7.4)
14 (17.3)
44 (54.3)
8 (9.9)
4 (4.9)
3 (9.1)
9 (27.3)
7 (21.2)
12 (36.4)
1 (3)
1 (3)
1 (6.7)
5 (33.3)
4 (26.7)
4 (26.7)
1 (6.7)
0
2 (5.1)
3 (7.7)
7 (17.9)
23 (59)
4 (10.3)
0
Job, n (%)
     Student (e)/apprentice
     Employee
     Unemployed/disability
     Retired
     Housewife/househusband
0     
58   (34.5)
44   (26.2)
63   (37.5)
3     (18)
0
30 (37)
15 (18.5)
35 (43.2)
1 (1.2)
0
7 (21.2)
16 (48.5)
8 (24.2)
2 (6.1)
0
6 (40)
5 (33.3)
4 (26.7)
0
0
15 (38.5)
8 (20.5)
16 (41)
0
Table 2a. Patient’s  socio-demographic characteristics, by follow-up.
Iqr¹=interquantile range of the median. *Poverty threshold definition according to the definition 
currently applied in Switzerland:<2200 
CHF/month=<26400 CHF/year for a person living alone.
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Parameters related to diabetes or metabolic syndrome characteristics Follow-up group
Number of patients N=168(%) DIAB 
N=81(48.2)
GP 
N=33(19.6)
C1 
N=15(8.9)
C2 
N=39(23.2)
Duration of type 2 diabetes Years, median  (iqr¹) 11 (10) 13 (12) 7 (9) 7 (9) 14 (9)
Diabetes and metabolic syndrome management
Insulin, n (%) 104 (61.9) 56 (69.1) 6 (18.2) 9 (60) 33 (84.6)
Total number of medicines, median (iqr¹) 5 (2) 5 (2) 4 (2) 6 (3) 6 (2)
Diabetes-related complications, median (iqr¹)
    Macrovascular complications
    Microvascular complications
    Mixed complications (macrovascular and 
    microvascular)
    Total vascular complications 
0 (1)
1 (2)
0
1 (2)
0 (1)
1 (2)
0
1 (1)
0 (1)
0 (1)
0
1 (1)
0 (1)
1 (3)
0
2 (2)
0 (1)
1 (2)
0
2 (1)
A1C: % (mmol/mol) 
median (iqr¹)
7.15 (58)
(1.5)
7.25 (56) 
(1.8)
7.1 (54)
(1.2)
7.1 (54)
(1.4)
7 (53)
(1.6)
Systolic arterial pressure, mmHg, median (iqr¹) 132 (22) 131 (22) 133 (22) 133.5 (19) 131.5 (27.5)
Diastolic arterial pressure, mmHg, median (iqr¹) 79  (14) 79 (14) 79.5 (13.5) 82 (8) 78 (16)
Urinary albumin/urinary creatinine ratio mg/
mmol, median (iqr¹)
1.4  (5.15) 1.4 (4.4) 1.36 (5.1) 7.3 (10.8) 1.15 (2.5)
Total cholesterol, mg/dl (mmol/l) 
median (iqr¹)
170.1 (4.4) 
 (1.35)
166.3 (4.3)
(1.5)
185.6 (4.8) 
(1.5)
150.8 (3.9)
(1.2)
166.3 (4.3) 
(1)
LDL-cholesterol, mg/dl (mmol/l) 
median (iqr¹)
85.1 (2.2) 
 (1)
77.3 (2) 
(1.1)
98.6 (2.55)
(1.2)
83.1 (2.15)
(1)
83.1 (2.15)  
(1)
Depressive and anxiety disorders characteristics
Major depressive disorder, median (iqr¹) 6   (3.6) 1 (1.2) 0 2 (13.3) 3 (7.7)
Minor depressive disorder, median (iqr¹) 20 (11.9) 7 (8.6) 6 (18.2) 2 (13.3) 5 (12.8)
Panic disorder, median (iqr¹) 0   (0) 0 0 0 0
Anxiety disorder other than panic disorder, 
median (iqr¹)
8   (4.8) 2 (2.5) 3 (9.1) 1 (6.7) 2 (5.1)
Table 2b: Patient’s parameters related to diabetes or to metabolic syndrome, depressive and anxiety disorders characteristics, by 
follow-up (N=168).
Iqr¹= interquantile range of the median.
Patient’s diabetes risk perception 
Risk perception subscales Follow-up group
N=168(%)
median (iqr)
DIAB 
N=81(48.2)
median (iqr)
GP 
N=33(19.6)
median (iqr)
C1 
N=15(8.9) 
median (iqr)
C2 
N=39(23.2) 
median (iqr)
Perception of control over diabetes 3.25 (0.5) 3.25 (0.5) 2.25 (0.5) 3 (1) 3.25 (0.5)
Diabetes-related worry 2.5 (1) 2.5 (1) 2.5 (1) 3 (1) 3 (1.5)
Optimistic bias 2 (0.5) 2 (0.5) 2.5 (0.5) 2 (1) 2 (1)
Perception of the risk related to the 
patient’s disease (range 1-5)
2.44 (0.9) 2.44 (0.9) 2.55 (0.9) 2.77 (0.8) 2.44 (0.9)
Diabetes risk knowledge (range 0-5) 5 (1) 5 (1) 5 (1) 5 (1) 5 (1)
Environment risk perception 1.66 (1) 1.77 (0.8) 1.66 (0.9) 2.33 (1.1) 1.66 (0.7)
Composite risk perception 2.21 (0.6) 2.14 (0.5) 2.26 (0.5) 2.67 (0.2) 2.25 (0.6)
Table 2c. Patient’s diabetes risk perception subscale, by follow-up.
All subscales are in range 1 (min)-4(max) except where noted differently.
Factors related to diabetes or to metabolic syndrome 
The median (iqr) age diabetes duration was 11(10) years, and 
over half suffered from microvascular complications (68.3% 
men and 53.3% women), but had fewer macrovascular compli-
cations overall (37.3%). Glycated haemoglobin, blood pressure, 
kidney function, albuminuria, and lipid profile values at the 
time of the study demonstrated very good disease control.  
Psychological characteristics
In terms of psychological profiles by the PRIME-MD/PHQ: 3.6% 
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exhibited symptoms of a major depressive disorder, 11.9% 
had a minor depressive disorder, and 4.8% had an anxiety 
disorder (other than panic disorder). 
Diabetes risk perception subscales
Patients had low median levels of perceived risk related to 
their disease (2.44), diabetes-related worry (2.5), optimistic 
bias (2), environment risk perception (1.66), and a low median 
composite risk perception (2.21). Patients had a high median 
level of perception of control over diabetes (3.25) and a very 
high perception of knowledge regarding risk (5). 
Diabetes risk perception subscales according to different 
follow-up
Patients of the C1 group, compared to the DIAB group, had 
higher perception of risk related to their disease (median 
level: 2.77 versus 2.44). These patients, compared to the DIAB 
group also had more diabetes-related worry (median level 
3 versus 2.5) and a higher level of composite risk perception 
(median level 2.67 versus 2.14). 
Logistic regression analysis of perceived risk
Among 168 patients, 138 (82.1%) had a higher perception of 
control over diabetes, 80 (47.6%) had higher diabetes-worry, 
36 (21.4%) had a higher optimistic bias, 39 (23.2%) had a higher 
perception of the risk related to diabetes complications, 146 
(86.9%) had a higher diabetes risk knowledge, 31 (18.4%) had 
a higher environment risk perception and 52 (30.9%) had a 
higher composite risk perception.
In the univariate analysis in logistic regression (Tables 
3a-3c), patients with combined specialty and general practi-
tioner follow-up (C1), compared to the DIAB follow-up, had 
*Types of follow-up Diabetes risk perception subscales (coded in two categories: low = 0 vs high = 1) OR (p)
Perception of 
control over 
diabetes
Diabetes-
related 
worry
Optimistic 
bias
Perception of the 
risk related to the 
patient’s disease
Diabetes risk 
knowledge
Environment 
risk perception
Composite risk 
perception 
GP 0.71 (0.49) 1.34 (0.48) 1.12 (0.82) 0.90 (0.85) 0.42 (0.15) 1.67 (0.31) 1.31 (0.57)
C1 0.62 (0.47) 6.45 (0.006) *** 3.55 (0.03) 0.38 (0.20) 1.90 (0.33) 14 (<0.0001)
C2 2.72 (0.13) 2.09 (0.06) 1.21 (0.68) 1.40 (0.46) 0.52 (0.27) 0.95 (0.93) 1.75 (0.19)
Socio demographic 
characteristics
Diabetes risk perception subscales OR (p)
Male 0.99  (0.99) 1.19 (0.62) 0.94 (0.88) 1.90 (0.16) 0.78 (0.65) 1.32 (0.56) 1.32 (0.47)
Age 0.95  
(0.03)
0.97 
(0.04)
1.04 
(0.048)
1.02 
(0.35)
0.95 
(0.05)
0.98 
(0.23)
0.98 
(0.19)
Place of birth 
Outside of  Switzerland 0.76 (0.49) 2.03 (0.03) 0.77 (0.5) 1 (0.99) 1.26 (0.63) 1.04 (0.91) 1.70 (0.12)
Educational level
Primary school**
Secondary school
Professional school
High school
Third-level/university
0.88 (0.85)
1.39 (0.62)
***
0.58 (0.40)
0.5 (0.22)
0.37 (0.05)
0.89 (0.89)
0.43 (0.11)
0.53 (0.39)
1.17 (0.78)
***
1.31 (0.66)
0.83 (0.77)
0.84 (0.76)
0.40 (0.44)
0.92 (0.88)
1.01 (0.99)
1.16 (0.84)
1.05 (0.97)
0.81 (0.78)
0.86 (0.83)
0.54 (0.33)
0.51 (0.57)
1.16 (0.35)
0.89 (0.85)
0.61 (0.35)
1.12 (0.89)
1.03 (0.95)
Annual household income
< 20.000 CHF**
     20.000-30.000 CHF
     30.000-50.000 CHF
> 50.000 CHF
I don’t know 
I refuse to answer
1.35 (0.72)
0.82 (0.80)
3.51 (0.10)
1.37 (0.73)
1.5   (0.76)
0.44 (0.28)
1.22 (0.78)
0.74 (0.64)
0.83 (0.82)
0.21 (0.22)
1.5 (0.74)
2.8 (0.36)
3.4 (0.26)
4 (0.25)
***
0.74 (0.72)
0.49 (0.4)
0.85 (0.82)
1.48 (0.65)
0.67 (0.76)
1.05 (0.95)
1.2 (0.84)
1.45 (0.66)
***
***
0.12 (0.08)
0.75 (0.71)
0.69 (0.61)
0.73 (0.73)
***
1.17 (0.85)
1.4 (0.66)
1.1 (0.91)
2 (0.42)
0.67 (0.76)
Job
Student/apprentice
     Employee**
Unemployed/disable
     Retired
     Housewife/-bound
***
0.84 (0.76)
0.51 (1.16)
***
***
0.81 (0.6)
0.57 (0.13)
***
***
0.81 (0.69)
1.45 (0.40)
8.54 (0.09)
***
1.26 (0.64)
1.71 (0.22)
***
***
0.9 (0.88)
0.54 (0.26)
***
***
0.55 (0.26)
0.73 (0.5)
1.73 (0.66)
***
1.06 (0.89)
0.82 (0.62)
***
Table 3a: Univariate logistic regression - type of follow-up, sociodemographic characteristics and diabetes risk perception subscales.
*DIAB=reference group, ** =reference group, ***=no patients in this group (perfect prediction)
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Parameters related to diabetes
or metabolic syndrome
characteristics
Diabetes risk perception subscales OR (p)
Perception of 
control over 
diabetes
Diabetes- 
related worry
Optimistic 
bias
Perception 
of the risk 
related to 
the patient’s 
disease
Diabetes risk 
knowledge
Environment 
risk perception
Composite 
risk  
perception
Duration of type 2 diabetes 0.93 (0.002) 1  (0.8) 0.99 (0.69) 1.05  (0.01) 0.99  (0.95) 1  (0.99) 1.04 (0.03)
Diabetes management
    Insulin 0.93 (0.86) 1.28 (0.43) 0.71 (0.38) 1.77 (0.15) 0.92 (0.86) 0.82 (0.63) 1.4  (0.33)
    Number of treatments 1.11  (0.35) 1.02  (0.78) 1.03 (0.77) 1.35 (0.008) 0.95 (0.68) 1.03  (0.77) 1.10 (0.3)
Diabetes-related complications
Macrovascular complications
Microvascular complications
Mixed vascular complications
Total vascular complications
1.22 (0.53)
0.82  (0.31)
***
0.95 (0.73)
0.92 (0.71)
1.29 (0.11)
0.54 (0.62)
1.11 (0.35)
1.16 (0.57)
0.88 (0.53)
***
0.96 (0.79)
1.28 (0.33)
1.47 (0.03)
1.67  (0.68)
1.31 (0.04)
0.84 (0.58)
0.99 (0.96)
***
0.96 (0.8)
1.22 (0.48)
1.08 (0.7)
***
1.08 (0.58)
1.3  (0.27)
1.49 (0.02)
1.12 (0.93)
1.32 (0.02)
A1C 1.09 (0.58) 1.17 (0.18) 0.8 (0.17) 0.92 (0.55) 1.03 (0.88) 0.74 (0.1) 1.05 (0.66)
Systolic arterial pressure (mmHg) 0.96 (0.004) 1 (0.80) 1 (0.83) 1.01 (0.22) 1 (0.57) 1 (0.82) 1.02 (0.03)
Diastolic arterial pressure 
(mmHg)
1.04 (0.08) 1.02 (0.2) 0.98 (0.32) 0.99 (0.49) 1.01 (0.65) 1 (0.97) 1 (0.85)
Urinary albumin/urinary  
creatinine ratio
1 (0.66) 1 (0.94) 1 (0.98) 1 (0.07) 1.02 (0.38) 1 (0.77) 1 (0.07)
Total cholesterol 0.95 (0.82) 1.17 (0.32) 0.99 (0.98) 0.64 (0.04) 0.9 (0.63) 0.97 (0.87) 0.93 (0.67)
LDL-cholesterol 0.83 (0.4) 1.5 (0.03) 0.80 (0.34) 0.93 (0.73) 0.92 (0.74) 1.3 (0.24) 1.27(0.21)
Table 3b. Univariate logistic regression - parameters related to diabetes and metabolic syndrome characteristicsand diabetes risk 
perception subscales.
*DIAB=reference group, **=reference group, ***=no patients in this group (perfect prediction)
Depressive and anxiety  
disorders characteristics
Diabetes risk perception subscales OR (p)
Perception of 
control over 
diabetes
Diabetes- 
related worry
Optimistic 
bias
Perception of 
the risk related 
to the patient’s 
disease
Diabetes 
risk  
knowledge
Environment 
risk  
perception
Composite 
risk  
perception
Major depressive disorder *** *** 0.72 (0.77) 0.65 (0.70) *** 0.88 (0.91) 2.3 (0.32)
Minor depressive disorder 2.1  (0.34) 1.4 (0.48) 0.61(0.046) 0.81 (0.72) 0.4 (0.10) *** 0.95 (0.92)
Anxiety disorder other than 
panic disorder
0.34 (0.15) 8.3 (0.05) *** 1.11 (0.90) 0.43 (0.32) 0.62 (0.66) 7.43 (0.02)
Table 3c. Univariate logistic regression-depressive and anxiety disorders characteristics and diabetes risk perception subscales.
*DIAB=reference group, **=reference group, ***=no patients in this group (perfect prediction)
higher composite risk perception (OR=14; 95% CI 3.55-55.06; 
p=<0.0001), higher diabetes-worry (OR=6.45; 95% CI 1.68-24.7; 
p=0.006) and higher risk perception for diabetes complications 
(OR=3.55; 95% CI 1.12-11.25; p=0.03). Older age was associ-
ated with lower perceived control over diabetes (OR=0.95; 
95% CI 0.91-0.99; p=0.03), lower diabetes-related worry 
(OR=0.97; 95% CI 0.94-1; p=0.04), higher odds of optimistic 
bias (OR=1.04; 95% CI 1-1.8; p=0.048) and lower diabetes risk 
knowledge (OR=0.95; 95% CI 0.91-1; p=0.05). Increased dura-
tion of diabetes was associated with lower odds of perceived 
control of diabetes (OR=0.93; 95% CI 0.89-0.97; p=0.002), but 
higher odds of perceived risk related to the patient’s illness 
(OR=1.05; 95% CI 1.01-1.09; p=0.012), and the composite 
perceived risk (OR=1.04; 95% CI 1-1.08; p=0.03). Specific 
microvascular complications and total vascular complica-
tions were positively correlated with perceived risk related 
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to the patient’s illness (OR=1.47; 95% CI 1.03-2.10; p=0.03 
and OR=1.31; 95% CI 1.08-1.69; p=0.04) and composite per-
ceived risk (OR=1.49; 95% CI 1.07-2.09; p=0.02 and OR=1.32; 
95% CI 1.04-1.69; p=0.02). Having an anxiety disorder other 
than panic disorder increased the odds for diabetes related 
worry (OR=8.3; 95% CI 1-69.4; p=0.05) and a higher composite 
perceived risk score (OR=7.43; CI 95% 1.45-39.19; p=0.02).
In the multivariate analysis (Table 4), there were no differ-
ences between the type of providers and the perception of 
control of diabetes. However C1 group (compared to DIAB 
group) had higher levels for worry of diabetes (OR 5.73; 95% 
CI 1.42-23.07; p=0.014), increased perceived risk related to 
the patient’s illness (OR 4.43; 95% CI 1.26-15.6; p=0.02) and 
better composite risk perception (OR 21; 95% CI 4.93-89.61; 
p=0). For the three other subscales, no model for a multivari-
ate analysis was possible.
Discussion
Perceived risk of diabetes by follow-up type
A significantly higher composite risk perception was associ-
ated with the combined follow-up group, when compared 
to all other groups. This was also true for perceived risk for 
diabetes complications and diabetes-related worry in rela-
Perception of control over diabetes
Duration of type 2 diabetes 0.93 (0.003)
Systolic arterial pressure (mmHg, median) 0.97 (0.05)
Type of follow-up (DIAB = reference group)
GP
C1
C2
0.37 (0.10) 
0.29 (0.09)
2.2 (0.27)
Diabetes-related worry
Age 0.96 (0.048)
LDL-cholesterol (mmol/l, median) 1.5   (0.042)
Type of follow-up (DIAB = reference group)
GP
C1
C2
0.99 (0.98)
5.73 (0.014)
1.66 (0.24)
Perception of the risk related to the patient’s disease
Duration of type 2 diabetes 1.05 (0.017)
Total number of medications 1.27 (0.054)
Type of follow-up (DIAB = reference group)
GP
C1
C2
1.68 (0.37)
4.43 (0.02)
1.25 (0.63)
Composite risk perception
Duration of type 2 diabetes 1.06 (0.005)
Anxiety disorder other than panic disorder 8.83 (0.015)
Type of follow-up (DIAB = reference group)
GP
C1
C2
1.76 (0.29)
21 (0)
1.72 (0.24)
Table 4. Multivariate logistic regression analysis of some diabetes 
risk subscales adjustable to some patient characteristics or types 
of follow-up.
tion to combined follow-up. These results show that being 
followed by several healthcare professionals who all work in 
the same centre (such as our polyclinic) increases/improves 
the perceived risk of this disease.
Improved metabolic control of diabetes has been docu-
mented within the context of an intensive team approach 
to diabetes management [12,13]. Intensive management of 
diabetes constitutes far more than an increased frequency 
of monitoring or an additional injection of insulin per day. 
It involves careful follow-up as well as an evaluation of the 
medical, educational and psychosocial needs of the patient. 
Diabetic patients manage their illness on a daily basis within 
the wider context of other goals, priorities, health issues and 
other personal concerns that make up their lives. The behav-
iours of these patients are often affected by multiple variables, 
as the kind of patient-physician relationship, complexity of 
regimen, disruption of lifestyle, emotional support, financial 
resources and education in self-management skills. These 
findings highlight the need to develop ways of empower-
ing patients within the context of multidisciplinary care [22].
Diabetes is associated with many comorbidities and 
challenging lifestyle recommendations. Consequently, it 
is difficult for any single physician to treat all of them in a 
single consultation. An interdisciplinary care model, like 
that of our polyclinic, offers goal-directed patient-centred 
care, with equal emphasis placed on education, counselling 
and medical treatment [13]. Integrated care shares provider 
responsibility while all members address common patient-
provider goals, and collaborate with, rather than just consult 
one another. It requires a unified team and the adoption of 
a shared professional identity with a marked team spirit as 
well as a common objective. A multidisciplinary team ap-
proach is the best way to manage diabetes, as shown by the 
results of multiple studies; medication alone is not enough 
to reduce diabetes complications and a multidisciplinary 
team approach to the management of diabetes is the most 
effective way to achieve better glycaemic control, improve 
blood pressure and lipid levels [23]. Many studies also show 
that a multidisciplinary approach to diabetes improves qual-
ity of life, decreases health costs, lowers risk of complications, 
increases follow-up and promotes higher patient satisfaction 
[24]. A combined follow-up in the same setting is also likely 
to facilitate the patient’s ability to access essential resources 
and care at any given time, which is probably linked to bet-
ter knowledge and increased risk perception. This is likely 
because each member of a larger interdisciplinary team can 
offer complementary management skills, more individual 
time for the assessment and treatment of patients. The group 
offers a more complete care model and facilitates stronger 
provider-patient foundations. Such teams assist patients in 
encouraging them to learn diabetes self-care through consist-
ent messages, repetition of information, reinforcement and 
feedback of self-care behaviours [25]. However, regular and 
ongoing communication among team members is necessary 
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for an effective team to function [25]. 
Diabetes risk subscales and their associations with 
patients’ characteristics, metabolic profile and psycho-
logical profile
Overall, composite risk perception was fairly low (2.27, range 
1–4, low level: 1-2.49), indicating that these patients have a 
low global diabetes risk perception. Patients also had low 
risk perception for diabetes complications (2.52, range 1–5, 
low level: 1-2.99). However, factors related to more complex 
disease (longer diabetes duration, increased number of 
drug therapies, increased microvascular and total vascular 
complications) were correlated with a higher perceived risk 
for diabetes complications. Interestingly, we did not find 
any studies that showed and explained why higher disease 
burden was associated with higher perceived risk.
The patients in our study displayed low optimistic bias 
(mean score: 2.24, range 1–4, low level: 1-2.99). Research in 
this area indicates that optimistic bias is lower in people with 
a higher level of education [10,19] and in people who were 
born in their country of residence [1]. Among people at risk 
of developing diabetes, men display more optimistic bias [11], 
which decreases if the epidemiological risk of developing the 
disease is greater [12]. Despite the absence of a statistically 
significant correlation in our study, the low optimistic bias 
may be accounted for by a good overall level of education, 
and coupled with better (higher) perception of the actual risk. 
Older age was significantly associated with greater optimistic 
bias (OR=1.04 ; 95% CI 1-1.8 ; p=0.048); the literature on this 
subject offers no clear explanation for this observation, but 
it has been shown that the elderly have a poorer perception 
of the risk of developing diabetes, a possible result of greater 
optimistic bias [13-16].
Finally, diabetes-related worry was low (mean score 2.66, 
range 1–4, low level: 1-2.99), and was significantly associated 
with the presence of any anxiety disorder except panic disorder 
(OR=8.3; 95% CI 1-69.4; p=0.05). Greater diabetes-related worry 
can be advantageous as it heightens risk perception, but if 
worry is excessive, it can be debilitating, and this anxiety can 
lower quality of life. For example, it has been documented 
that excessive worry narrows the patient’s field of perception 
to the present cause of stress, reduces cognitive capacity 
(ability to elaborate on information about their health) and 
prevents patients from taking a more active part in their 
disease management [17,18].
Diabetes risk perception subscales compared to original 
RPS-DM study
Our study population had higher risk perception for most of 
the subscales, and higher overall values compared to those 
in Walker’s findings for the RPS-DM questionnaire in an urban 
study population [1]. Our results show higher perception of 
control over diabetes (3.23/2.9, range 1–4), less optimistic 
bias (2.24/2.4, range 1–4) and higher knowledge of diabetes 
risk (4.33/3.7, range 0–5). Diabetes-related worry was lower 
than the Walker study (2.66/3.1, range 1–4).
In our investigation (unlike in E.A. Walker’s study), no 
statistically significant correlation was found between level 
of education and the risk perception subscales. The overall 
good level of education of our patients may explain this result. 
Strengths and limitations
To our knowledge, this is the first study to evaluate the effects 
of combined care on risk perception among patients with 
diabetes. We examined associations between subscales of 
diabetes risk perception and socio-demographic characteris-
tics similar to a large previous study [1]. However, the current 
study also investigated the associations of risk perception 
with metabolic syndrome and psychological characteristics of 
patients, an added improvement on previous work in this area. 
The advantages of a combined follow-up, especially when 
in the same institution, are probably the best explanation 
of this increased risk perception, but other factors could 
interfere with this result; patients of the C1 group, compared 
to patients of the DIAB group, had lower socio-economic 
status (within this group unemployment is higher and their 
annual income is, on the whole, lower), are younger and with 
a younger diabetes and parts of these factors could influence 
some aspects of risk perception [1].
Interestingly, we did not find a better risk perception of 
diabetes among patients who had a combined follow-up with 
physicians who do not practice in the same institution (C2 
group) compared to patients of the DIAB group. This could 
be explained by a possible difficulty to provide patients with 
a coherent health message as well as offering a coordinated 
care as with a combined follow-up in the same institution.
Since this study is cross-sectional, it is not possible to estab-
lish the direction of the relationship between type follow-up 
and diabetes risk perception. The patients in each group may 
be highly self-selected, thus there may be reverse causation 
as well: the patients with higher risk perception may choose 
different follow-up methods, or doctors may be more likely 
to refer them differently.
Due to the lack of power of our study (mainly for the com-
bined follow-up group), it was not possible to analyse whether 
patients’ characteristics associated with type of follow-up 
were statistically relevant and, clinically, had a real impact 
on different risk perception according to type of follow-up.
The small number of patients included constitutes one of 
the major limitations of our study. Many non-French speak-
ers, patients from the polyclinic, were excluded based on 
linguistic competence. Furthermore, the population of this 
institution (serving a significant portion of the underserved in 
the area) does not accurately reflect the socio-demographic 
reality of the entire population of Lausanne. Finally, due to the 
low turnout rate of participants, our results should be inter-
preted with caution. Despite a better/higher risk perception 
of diabetes, patients in the combined follow-up group, did 
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not have a better biological profile or lower blood pressure 
values compared to other groups; however, it was difficult to 
detect any small differences in disease profile given the small 
size of the comparison groups, and the overall good disease 
profile for the study population, in general.
Conclusion
To our knowledge, this is the first study to analyse several 
domains of diabetes risk perception with “a validated French” 
version of E.A. Walker’s RPS-DM survey [1]. Our results suggest 
that the collaboration by several healthcare professionals (dia-
betologists and general practitioners) who work at the same 
centre may improve their patients’ diabetes risk perception. 
Annual income, age, diabetes duration, the number of vascu-
lar complications, and the presence of any anxiety disorder 
other than panic disorder were the factors most significantly 
associated with higher diabetes risk perception subscales.
Given that this is a pilot study, the next steps include a 
multi-centric longitudinal study examining these relationships 
among different provider group types. Future research should 
also better explore the link between perception of diabetes 
complications and a more severe disease.
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